drugset / Trial / NCT03618589

Pregabalin add-on for Neuropathic Pain in Cervical Myelopathy

NCT03618589

Phase 1 Unknown 60 enrolled Seoul National University Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

There is no information on the effect of pregabalin in patients with neuropathic pain in cervical myelopathy under routine clinical practice. The investigators will conduct this prospective, randomized trial to determine the efficacy of pregabalin for neuropathic pain in cervical myelopathic patients in order to validate or refute this popular practice. The primary aim of this study was to compare Leeds assessment of neuropathic symptoms and signs scale (LANSS) scores of neuropathic pain in cervical myelopathy patients.

Timeline

Start
2016-11-26
Primary completion
2019-12-31
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 300 mg
Background Oxycodone Other / unclassified 5 mg

Indications